Porto-sinusoidal vascular disorder.

Détails

Ressource 1Télécharger: 35690264.pdf (3029.76 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_B35EED5B7938
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Porto-sinusoidal vascular disorder.
Périodique
Journal of hepatology
Auteur⸱e⸱s
De Gottardi A., Sempoux C., Berzigotti A.
ISSN
1600-0641 (Electronic)
ISSN-L
0168-8278
Statut éditorial
Publié
Date de publication
10/2022
Peer-reviewed
Oui
Volume
77
Numéro
4
Pages
1124-1135
Langue
anglais
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Résumé
It is well established that portal hypertension can occur in the absence of cirrhosis, as reported in patients with immune disorders, infections and thrombophilia. However, similar histological abnormalities primarily affecting the hepatic sinusoidal and (peri)portal vasculature have also been observed in patients without portal hypertension. Thus, the term porto-sinusoidal vascular disorder (PSVD) has recently been introduced to describe a group of vascular diseases of the liver featuring lesions encompassing the portal venules and sinusoids, irrespective of the presence/absence of portal hypertension. Liver biopsy is fundamental for PSVD diagnosis. Specific histology findings include nodular regenerative hyperplasia, obliterative portal venopathy/portal vein stenosis and incomplete septal fibrosis/cirrhosis. Since other conditions including alcohol-related and non-alcoholic fatty liver disease, or viral hepatitis, or the presence of portal vein thrombosis may occur in patients with PSVD, their relative contribution to liver damage should be carefully assessed. In addition to histology and clinical diagnostic criteria, imaging and non-invasive tests such as liver and spleen stiffness measurements could aid in the diagnostic workup. The introduction of PSVD as a novel clinical entity will facilitate collaborative studies and investigations into the underlying molecular pathomechanisms encompassed by this term.
Mots-clé
Fibrosis, Humans, Hypertension, Portal/complications, Hypertension, Portal/diagnosis, Liver/pathology, Liver Cirrhosis/diagnosis, Portal Vein/pathology, Vascular Diseases/diagnosis, Vascular Diseases/etiology, Vascular Diseases/pathology, idiopathic noncirrhotic portal hypertension, incomplete septal fibrosis, nodular regenerative hyperplasia, obliterative portal venopathy, portal vein stenosis
Pubmed
Web of science
Open Access
Oui
Création de la notice
13/06/2022 8:06
Dernière modification de la notice
21/11/2022 9:11
Données d'usage